Oral Medicament For The Modified Release Of At Least One Active Principle, In Multimicrocapsule Form
AssigneeFlamel Technologies
InventorsFlorence Guimberteau, Catherine Castan, Remi Meyrueix, Gerard Soula
Life of this patent
Estimating the term…
Loading patent…
AssigneeFlamel Technologies
InventorsFlorence Guimberteau, Catherine Castan, Remi Meyrueix, Gerard Soula
Estimating the term…
The field of the invention is that of oral medicaments or pharmaceutical compositions, in particular of the type including one or more active principles. The aim of the invention is to provide an improved oral medicament to be administered in one or several daily doses and enabling the modified release of active principles (in particular of one active principle), whereby the prophylactic and therapeutic effectiveness of said medicament is improved. This aim is achieved by the oral multimicrocapsule galenic form according to the invention, in which the active principle release is controlled by a dual release trigger mechanism: “time-dependent trigger” and “pH-dependent trigger”. Said medicament includes microcapsules providing the modified release of the active principle, each comprising a core containing
An oral medicament comprising a plurality of microcapsules for the modified release of active principle(s), at least some of said microcapsules consisting individually of a microparticle comprising at least one active principle, in particular at least one low-solubility active principle (with the exclusion of carvedilol), coated with at least one coating for the modified release of the active principle(s), said release being controlled by two distinct trigger mechanisms, one being based on a variation in pH and the other allowing the release of the active principle(s) after a predetermined period of time spent in the stomach,
The medicament as claimed in one of the preceding claims, characterized in that it comprises at least one wetting agent, preferably chosen from the group of following products:
The medicament as claimed in one of the preceding claims, characterized in that the swelling agent and/or the wetting agent is contained in the microparticle of active principle.
The medicament as claimed in one of the preceding claims, characterized in that the microcapsules of active principle(s) that it comprises are capable of releasing at least 80% by weight of the active principle(s), after 12 h at pH=7.0, in an in vitro dissolution test.
The medicament as claimed in one of the preceding claims, characterized in that at least some of the microcapsules for the modified release of active principle(s) each comprise:
The medicament as claimed in one of the preceding claims, characterized in that at least some of said microcapsules for the modified release of active principle comprise:
The medicament as claimed in one of the preceding claims, characterized in that:
An oral medicament comprising a plurality of microcapsules for the modified release of active principle(s), at least some of said microcapsules consisting individually of a microparticle comprising at least one active principle, in particular at least one low-solubility active principle (with the exclusion of carvedilol), coated with at least one coating for the modified release of the active principle(s), said release being controlled by two distinct trigger mechanisms, one based on a variation in pH and the other allowing the release of the active principle(s) after a predetermined period of time spent in the stomach,
The medicament as claimed in one of the preceding claims, characterized in that it is in the form of a single daily oral dose comprising from 5000 to 500 000 microunits containing active principle(s).
The medicament as claimed in one of the preceding claims, characterized in that it is in the form of a single daily oral dose comprising from 5000 to 500 000 microcapsules for the modified release of active principle(s).
The medicament as claimed in one of the preceding claims, characterized in that it is in the form of a sachet of microcapsule powder, of a liquid suspension of microcapsules, of a tablet obtained from microcapsules, or of a gelatin capsule containing microcapsules.
The medicament as claimed in one of the preceding claims, characterized in that the active principle(s) can be chosen from at least one of the following main varieties of active substances, e.g.:
The medicament as claimed in one of the preceding claims, characterized in that the active principle(s) is (are) chosen from the group of products comprising:
The medicament as claimed in one of the preceding claims, characterized in that the active principle(s) is (are) a low-solubility active principle or low-solubility active principles.
The microcapsule as defined in any one of the preceding claims.
Dependencies are inferred from the claim text.